Showing results (391-400 of 427) with videos related to
Sort By:
Pageof 43
Journal of the National Cancer Institute|December 21, 2006
Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition StudyRowan T Chlebowski, George L Blackburn, Cynthia A Thomson, et al.European Journal of Cancer (Oxford, England : 1990)|July 6, 2019
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trialsM Martín, S Loibl, T Hyslop, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2013
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast CancerAyca Gucalp, Sara Tolaney, Steven J Isakoff, et al.Obesity (Silver Spring, Md.)|December 21, 2021
The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle interventionLinda M Delahanty, Thomas A Wadden, Pamela J Goodwin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2016
The Genomic Landscape of Male Breast CancersSalvatore Piscuoglio, Charlotte K Y Ng, Melissa P Murray, et al.Obesity (Silver Spring, Md.)|November 1, 2017
American Society of Clinical Oncology Summit on Addressing Obesity Through Multidisciplinary Provider Collaboration: Key Findings and Recommendations for ActionJennifer A Ligibel, Catherine M Alfano, Dawn L Hershman, et al.The Lancet. Oncology|December 17, 2009
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialKathy S Albain, William E Barlow, Steven Shak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657Laura J Esserman, Donald A Berry, Angela DeMichele, et al.Cancer Prevention Research (Philadelphia, Pa.)|February 18, 2018
A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast DiseaseAyca Gucalp, Xi K Zhou, Elise D Cook, et al.NPJ Breast Cancer|July 11, 2017
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)Minetta C Liu, Brandelyn N Pitcher, Elaine R Mardis, et al.Pageof 43